At a glance
- Originator Mitsubishi Pharma Corporation
- Class Antiulcers; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 21 May 2001 Discontinued-Preclinical for Peptic ulcer in Japan (PO)
- 16 Apr 1997 No-Development-Reported for Peptic ulcer in Japan (PO)